Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2004 1
2006 1
2008 3
2009 4
2010 2
2011 5
2012 4
2013 4
2014 5
2015 6
2016 3
2017 3
2018 4
2021 4
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Estimating preferences for treatments in patients with localized prostate cancer.
Ávila M, Becerra V, Guedea F, Suárez JF, Fernandez P, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Sancho G, Cunillera O, Pardo Y, Cots F, Ferrer M; Multicentric Spanish Group of Clinically Localized Prostate Cancer. Ávila M, et al. Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):277-87. doi: 10.1016/j.ijrobp.2014.09.044. Epub 2014 Dec 6. Int J Radiat Oncol Biol Phys. 2015. PMID: 25491504
Prognostic Factors and Decision Tree for Long-Term Survival in Metastatic Uveal Melanoma.
Lorenzo D, Ochoa M, Piulats JM, Gutiérrez C, Arias L, Català J, Grau M, Peñafiel J, Cobos E, Garcia-Bru P, Rubio MJ, Padrón-Pérez N, Dias B, Pera J, Caminal JM. Lorenzo D, et al. Among authors: pera j. Cancer Res Treat. 2018 Oct;50(4):1130-1139. doi: 10.4143/crt.2017.171. Epub 2017 Dec 4. Cancer Res Treat. 2018. PMID: 29198096 Free PMC article.
Five-year quality of life in patients with high-risk localized prostate cancer treated with external beam radiotherapy alone versus external beam radiotherapy with high-dose-rate brachytherapy boost: a prospective multicenter study.
Martínez E, Garin O, Pardo Y, Fernández P, Guix B, Gutiérrez C, Boladeras A, Ferrer F, Hernández T, Ayala A, Egiguren M, Fernández G, Muñoz V, Macías V, Pera J, Pont À, Ferrer M, Guedea F; Multicentric Spanish Group of Clinically Localized Prostate Cancer; Multicentric Spanish Group of Clincally Localized Prostate Cancer: Montse Ferrer, Àngels Pont, Olatz Garin, Yolanda Pardo, Jordi Alonso, Mónica Ávila, Víctor Zamora, Ferran Guedea, Montse Ventura, Cristina Gutiérrez, Ferran Ferrer, Ana Boladeras, José Francisco Suárez, Manel Castells, Xavier Bonet, Pastor S, Carmen Bonet, Gemma Sancho, Javier Ponce de León, Joan Palou, Belén de Paula, Alai Goñi, Pablo Fernández, Ismael Herruzo, Asunción Hervás, Alfredo Ramos, Víctor Macías, Josep Solé, Marta Bonet, Alfonso Mariño, Patricia Cabrera, Maria José Ortiz. Martínez E, et al. Among authors: pera j. J Contemp Brachytherapy. 2021 Feb;13(1):1-11. doi: 10.5114/jcb.2021.103580. Epub 2021 Feb 18. J Contemp Brachytherapy. 2021. PMID: 34025730 Free PMC article.
43 results